Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
Recruiting · NCT07101094 · Observational (researchers observe without assigning treatment) · Lead sponsor: Bristol-Myers Squibb
View the official record on ClinicalTrials.gov →Interventions studied
xanomeline and trospium chloride (X/T) therapy
What this trial is about
The purpose of this study is to understand treatment preference and satisfaction among adults with schizophrenia in the United States who are prescribed xanomeline and trospium chloride (X/T) therapy
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Aged ≥18 years at index date.
- Have a confirmed diagnosis of schizophrenia before index date.
- Receipt of an initial prescription order for xanomeline and trospium chloride (XT) and plan to fill and initiate such therapy.
- Provide a signed and dated Institutional Review Board (IRB)/Independent Ethics Committee (IEC)-approved written informed consent form (ICF) in accordance with regulatory, local, and institutional guidelines.
- Agree to use an electronic device to record, or provide paper entry of, patient-reported outcomes (in English or Spanish).
- English or Spanish speaking.
Exclusion criteria
- Participation in an interventional study within the last 30 days or plan to participate in such study at the time of eligibility screening.
- Evidence of use of XT prior to time of eligibility screening.
Where it is running
20 locations listed across 12 US states.
- ATP Clinical Research - Costa Mesa, California, United States
- Lumos Clinical Research Center - San Jose, California, United States
- Local Institution - 0019 - Miami, Florida, United States
- Evanston Hospital - Evanston, Illinois, United States
- The Johns Hopkins Hospital - Baltimore, Maryland, United States
- Local Institution - 0017 - Bel Air, Maryland, United States
- Local Institution - 0004 - Catonsville, Maryland, United States
- Local Institution - 0008 - Belmont, Massachusetts, United States
- Boston Medical Center - Boston, Massachusetts, United States
- Mayflower Clinical - South Dartmouth, Massachusetts, United States
- Local Institution - 0020 - Grand Island, Nebraska, United States
- Omaha Insomnia and Psychiatric Services - Omaha, Nebraska, United States
- Hackensack Meridian Health - Carrier Clinic - Belle Mead, New Jersey, United States
- Radial - Manhattan - New York, New York, United States
- New Dawn Psychiatric Services, PLLC - Kinston, North Carolina, United States
- New Dimension Group - Rose Hill, North Carolina, United States
- Westlake Brain Health - Westlake, Ohio, United States
- Continuum Health Providers - Fort Mill, South Carolina, United States
- Haracec Clinical Research - El Paso, Texas, United States
- C-Trilogy Outreach - Longview, Texas, United States